Cargando…
Skeletal Muscle Dysfunction in Experimental Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a serious, progressive, and often fatal disease that is in urgent need of improved therapies that treat it. One of the remaining therapeutic challenges is the increasingly recognized skeletal muscle dysfunction that interferes with exercise tolerance. Here we...
Autores principales: | Kosmas, Kosmas, Michael, Zoe, Papathanasiou, Aimilia Eirini, Spyropoulos, Fotios, Adib, Elio, Jasuja, Ravi, Christou, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501428/ https://www.ncbi.nlm.nih.gov/pubmed/36142826 http://dx.doi.org/10.3390/ijms231810912 |
Ejemplares similares
-
Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension
por: Papathanasiou, Aimilia Eirini, et al.
Publicado: (2021) -
Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension
por: Spyropoulos, Fotios, et al.
Publicado: (2021) -
Echocardiographic markers of pulmonary hemodynamics and right
ventricular hypertrophy in rat models of pulmonary hypertension
por: Spyropoulos, Fotios, et al.
Publicado: (2020) -
Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches
por: Michael, Zoe, et al.
Publicado: (2018) -
Skeletal and Respiratory Muscle Dysfunctions in Pulmonary Arterial Hypertension
por: Riou, Marianne, et al.
Publicado: (2020)